National Institute of Allergy and Infectious Diseases
  National Institutes of Health
NIAID Home Health & Science Research Funding Research News & Events Labs at NIAID About NIAID
 
All |  A |  B |  C |  D |  E |  F |  G |  H |  I |  J |  K |  L |  M |  N |  O |  P |  Q |  R |  S |  T |  U |  V |  W |  X |  Y |  Z
TitleLast Updated
A "State-of-the-Art" Conference on Hepatitis C May 6, 2008
A Case Study Approach to the Clinician's Challenge in Preserving Long-term Renal Function, Implication of Preserving Long-term Renal Function After Renal Transplantation, NIAID, NIH, DHHS Oct. 25, 2007
A Deadly Synergy, Tuberculosis (TB), NIAID, NIH April 1, 2005
A Delicate Balance: Levels of HIV Replication are Strongly Influenced by Interaction of Positive and Negative Host Factors July 9, 1996
A Framework for Progress on Hepatitis C May 6, 2008
A Global Threat, Leishmaniasis, NIAID, NIH Aug. 11, 2008
A Killer Returns: The Face of the Epidemic, Tuberculosis, NIAID, NIH April 1, 2005
A Leading Cause of Blindness May Be Controlled by Simple Course of Oral Antibiotic Aug. 19, 1999
A Microbe Hunter On Call to the World, Discovery News, NIAID, NIH May 9, 2008
A Multiple-reach Model Describing the Migratory Behavior of Snake River Yearling Chinook Salmon (Oncorhynchus tshawytscha), Can. J. Fish. Aquat. Sci. 55, 1998 Aug. 6, 2007
A New Registry for Primary Immune Deficiency Diseases Oct. 30, 1997
A Parasite, a Virus, and a Bacterium: NIAID's Plan to Tackle the World's Leading Killers, NIAID May 7, 2001
A Phase IIB randomized, controlled trial to evaluate the safety, tolerance, and HIV vertical transmission rates associated with short course nevirapine (NVP) vs. short course zidovudine (ZDV) in HIV infected pregnant women and their infants in Uganda July 15, 1999
A Potential New Target for Treating Asthma, NIAID, NIH Dec. 1, 2006
A Risky Business, Anthony S. Fauci, Washington Times, November 30, 2004 Aug. 6, 2007
A Safety Evaluation of MDCK for Influenza Vaccine Production, Vaccine Cell Substrate 2004, Practical Experience April 11, 2008
A Small Genetic Change Makes Flu Virus Deadly Sept. 6, 2001
A Timely Test: Real Time PCR, Tuberculosis (TB), NIAID, NIH April 1, 2005
A view from Washington through the eyes of an AAP physician-scientist, Anthony Fauci, Journal of Clinical Investigation, October 2007 Dec. 26, 2007
Abnormal Immune Cells May Cause Unprovoked Anaphylaxis Nov. 13, 2007
About CMB, Comparative Medicine Branch July 6, 2006
About NIAID June 14, 2005
About NIAID Labs March 13, 2007
About the DAIDS Clinical Research Policies and Standard Procedures Documents, NIAID, NIH Nov. 28, 2007
About the DMID Office of Clinical Research Affairs (OCRA), NIAID, NIH April 19, 2007
About the Research Technologies Branch, NIAID, NIH Sept. 5, 2006
About the TB Bug, Tuberculosis, NIAID, NIH April 1, 2005
About, NIAID HIV and Emerging Infectious Diseases Program, NIAID, NIH Oct. 17, 2006
Abstract: “Enteric Vaccines for Pediatric Use” Workshop Report, April 24-26, 2004, NIAID, NIH Aug. 6, 2007
Abstract: “Hit” to Clinical Candidate: Discovery and Characterization of the Aminomethylcyclines Sept. 7, 2007
Abstract: Antiviral Drug Development for Biothreat Agents, Tove C. Bolken, Head of Research Operations, SIGA Technologies, Inc. Sept. 7, 2007
Abstract: Bacillus anthracis Antimicrobials Derived from Inhibitors of Mammalian Serine-Threonine Kinases, Jimmy D. Ballard, Ph.D. Sept. 7, 2007
Abstract: Challenges of Antibiotic Drug Development in the 21st Century, Karen Bush, Ph. D., Sept. 7, 2007
Abstract: Chop-lump Tests for Vaccine Trials, September 4, 2007 Sept. 20, 2007
Abstract: Combining Focused Antisense Screening Technology (FAST) and Structure-based Drug Design (SBDD) for Antibacterial Discovery Sept. 7, 2007
Abstract: Development of Antiviral RNA Interference Therapeutics, Antonin de Fougerolles Sept. 7, 2007
Abstract: Development of Cysteine Cathepsin Inhibitors as Anti-Ebola Virus Agents - James M. Cunningham Sept. 7, 2007
Abstract: Discovery of Smallpox Inhibitors that Block Processive DNA Synthesis Sept. 7, 2007
Abstract: Dose and Schedule Choices to Suppress Emergence of Resistance G.L. Drusano, M.D., Ordway Research Institute Sept. 7, 2007
Abstract: Efflux Pump Inhibitors: from Tools to Drugs Sept. 7, 2007
Abstract: Identification of Inhibitors of Ebola Virus Using a Subgenomic Replication System Sept. 7, 2007
Abstract: Identification of Small Molecule Inhibitors of Anthrax Lethal Factor Sept. 7, 2007
Abstract: Impact of Drug-Like Properties on Hit Selection and Optimization for Quality Clinical Candidates Sept. 7, 2007
Abstract: Leveraging Structure-Based Drug Design Technologies to Accelerate Drug Candidate Generation Sept. 7, 2007
Abstract: Multi-target Anthrax Antitoxin Therapies, February 7, 2007 Sept. 7, 2007
Abstract: Nucleotides as Anti-HBV Agents, R. P. Iyer, Ph.D. Sept. 7, 2007
Abstract: Old Target, New Approach: Developing Pterin-like Small Molecules as Inhibitors of the Bacterial Folate Pathway Sept. 7, 2007
Abstract: Optimizing the Oral Bioavailability and Activity of Antiviral Drugs, Karl Y. Hostetler Sept. 7, 2007
Abstract: Pitfalls of Target Validation for Novel Antibacterial Strategies, David J. Payne Sept. 7, 2007
Abstract: The Discovery of Orally Active Inhibitors of Respiratory Syncytial Virus, Nicholas A. Meanwell Sept. 7, 2007
Abstract: Use of a Cocktail to Reduce the Need for Drug Interaction Studies During Drug Development - Joseph S. Bertino Jr., Pharm.D., FCP Sept. 7, 2007
Acellular Pertussis Vaccine Proves Effective in Adults, Adolescents Oct. 12, 2005
Achievements and Goals, Chemical Countermeasures, NIAID, NIH March 3, 2008
Achieving and Maintaining Polio Eradication, Polio Immunization: Moving Forward, September 19-20, 2007 Dec. 26, 2007
Acquired Immunodeficiency Review Committee, About NIAID, NIAID, NIH July 22, 2004
Acquired Immunodeficiency Syndrome (AIDS) Panel, US-Japan Cooperative Medical Science Program, NIAID, NIH Nov. 16, 2007
Acquired Immunodeficiency Syndrome (AIDS), Selected Scientific Areas of Research Dec. 23, 2004
Acronyms, Comparative Medicine Branch July 2, 2006
ACTG 175, CPCRA 007 Trial Results Published Oct. 9, 1996
ACTG 175: Anti-HIV Therapy Lowers Risk of AIDS Sept. 14, 1995
ACTG 315 Preliminary Results: Drug Cocktail Restores Partial Immune Function Jan. 26, 1997
Actividades del Día de Concientización Sobre la Vacuna Contra el VIH/SIDA, 18 de mayo del 2005 July 30, 2007
Actividades del Día de Concientización Sobre las Vacunas Contra el VIH 18 de Mayo del 2006 July 30, 2007
Acute Respiratory Infections Panel, US-Japan Cooperative Medical Science Program, NIAID, NIH March 10, 2005
Adaptively Changing Subgroup Proportions in Clinical Trials, Dean Follman, Statistica Sinica 1997 July 25, 2007
Add Your Voice, Division of AIDS (DAIDS), NIAID, NIH Sept. 11, 2008
Add Your Voice: Opportunties for Community Participation in HIV/AIDS Research, DAIDS, NIAID, NIH July 30, 2007
Adding IL-2 to Potent Anti-HIV Drugs Increases CD4+ T-Cell Counts Without Raising HIV Levels July 8, 2000
Additional Questions and Answers to RFP NIH-NIAID-DMID-PR2004-01 ‘Neutralizing Monoclonal Antibodies Type A for Botulinum Neurotoxins’ Sept. 12, 2007
Additional Questions and Answers to the RFP No. NIH-NIAID-DMID-PR2004-02, ‘Recombinant Type E Botulinum Neurotoxin Vaccine’ Sept. 12, 2007
Additional Resources, HIV/AIDS Specimen Repository May 15, 2008
Additional Resources, New Investigator Workshot, DAIT, NIAID, NIH Nov. 7, 2007
Addressing Antimicrobial Resistance, Slide 7, Testimony of Dr. Fauci, February 25, 1999 Feb. 24, 1999
Addressing Health Disparities: NIAID Agenda, Slide 9, Dr. Anthony S. Fauci, March 1, 2000 March 1, 2000
Adenovirus Potency Assays: Novel Approaches to Current Challenges April 11, 2008
Adjournment, National Advisory Allergy and Infectious Diseases Council January 2005 Minutes March 15, 2005
Adjournment, National Advisory Allergy and Infectious Diseases Council September 1997 Minutes March 13, 2001
Adjournment, National Advisory Allergy and Infectious Diseases Council: February 2000 Minutes March 2, 2001
Adjournment, National Advisory Allergy and Infectious Diseases Council: September 1998 Minutes March 12, 2001
Adjuvants and Other Vaccine Ingredients, Vaccines, NIAID, NIH Sept. 4, 2008
Adriana Marques, M.D., Clinical Studies Unit, Laboratory of Clinical Infectious Diseases, NIAID, NIH June 13, 2008
Adult Male Circumcision Reduces Risk of HIV Acquisition for at Least 3.5 Years Aug. 11, 2008
Adult Male Circumcision Significantly Reduces Risk of Acquiring HIV: Trials in Kenya and Uganda Stopped Early Dec. 13, 2006
Adult Male Circumcision Significantly Reduces Risk of Acquiring HIV: Trials in Kenya and Uganda Stopped Early Dec. 13, 2006
Advanced Product Development for Multiplex Infectious Disease Diagnostics: Summary of a NIAID Workshop Aug. 6, 2007
Advances in AIDS Pathogenesis and Preclinical Vaccine Development April 29, 1997
Advances in Treatment, Flu (Influenza), NIAID, NIH Nov. 28, 2006
Advances in Treatment, Tuberculosis (TB), NIAID, NIH July 17, 2008
Adventitious Virus Tests, Vaccine Cell Substrates 2004, June 30, 2004 April 11, 2008
Advisory and Working Groups, HIV/AIDS Vaccines, NIAID, NIH Sept. 12, 2007
Aedes Aegypti Announcement, October 2005, Pathogen Genomics, Research, NIAID, NIH Jan. 5, 2006
Aedes Announcement, June, Pathogen Genomics, Research, NIAID, NIH July 26, 2006
Aerosol Challenge Technology and Applications in Biodefense “Biological Safety” Sept. 12, 2007
Aerosol Challenge Technology and Applications in Biodefense, Biodefense, NIAID, NIH Feb. 7, 2007
Aerosol delivery of MTB and Chemotherapeutics: Pitfalls and Plans, Laura E. Via, Ph.D. Sept. 12, 2007
Aerosol Generation Sept. 12, 2007
Aerosol Parameters (Historical) Sept. 12, 2007
Aerosolized filoviruses in three species of nonhuman primates: Differences in disease course and pathology Dec. 26, 2007
Africa Malaria Day and Malaria Awareness Day, April 25, 2007, NIAID, NIH April 25, 2007
Africa, Global Research, NIAID, NIH Sept. 15, 2008
African Americans Inspiring Hope May 17, 2005
African Americans: Answers about HIV Vaccine Research, NIAID, NIH Sept. 11, 2008
Age of Optimism, Tuberculosis (TB), NIAID, NIH Feb. 28, 2006
Age-Based Screening is Cost-Effective Method to Control Chlamydial Infection Feb. 17, 1998
Agenda - OPV Dec. 26, 2007
Agenda, 40th Tuberculosis and Leprosy Research Conference, US-Japan Cooperative Medical Science Program, NIAID, NIH July 25, 2007
Agenda, Mycobacteria Symposium, NIAID, NIH Sept. 3, 2008
Agenda, Pediatric Tuberculosis Meeting, NIAID, NIH June 3, 2008
Agenda, Polio Immunization: Moving Forward, September 19-20, 2007, NIH Aug. 1, 2007
Agenda, Vaccines for Viral Infections in Developing Countries Aug. 2, 2006
Agenda: 40th Tuberculosis and Leprosy Research Conference, US-Japan Cooperative Medical Science Program Aug. 6, 2007
Agenda: Medical Countermeasures against Combined Injury: Radiation with Burn, Blast, Trauma and/or Sepsis, March 26 - 27, 2007 Aug. 6, 2007
Agenda: Prevention of Group A Streptococcal Diseases and Their Sequelae Aug. 16, 2007
Agricultural Workers at Increased Risk for Infection with Animal Flu Viruses Nov. 25, 2005
AIDS Care in Africa Meeting, Kampala, Uganda, April 18-20, 2001, Slide 18, Dr. Anthony S. Fauci, July 7, 2001 July 7, 2001
AIDS Clinical Trials Group: Affiliated Clinical Trials Units and Clinical Research Sites July 24, 2007
AIDS Deaths in the United Stated: January 1985-June 1997, Slide 4, Dr. Anthony S. Fauci, September 16, 1998 Jan. 14, 1999
AIDS Deaths in the United States, 1/86-9/98, Slide 4, Dr. Anthony S. Fauci, July 9, 1999 July 16, 1999
AIDS Deaths in the United States, 1985-2000, Slide 20, Dr. Anthony S. Fauci, July 7, 2001 July 7, 2001
AIDS Deaths in the United States, January 1986 - June 1998, Slide 2, Dr. Anthony S. Fauci, 1999 March 5, 1999
AIDS Deaths in the United States: January 1985-June 1997, Poster 2 Jan. 18, 2005
AIDS Deaths in the United States: January 1985-June 1997, Slide 1, Dr. Anthony S. Fauci, March 18, 1998 Jan. 15, 1999
AIDS Drugs Have Saved 3 Million Years of Life in the United States June 2, 2006
AIDS Research Advisory Committe, NIAID, NIH May 28, 2008
AIDS Research and Prevention, Slide 8, Dr. Anthony S. Fauci, September 16, 1998 Jan. 14, 1999
AIDS Research, Slide 10, Dr. Anthony S. Fauci, July 9, 1999 July 16, 1999
AIDS Vaccine 2007 Report Jan. 8, 2008
AIDS Vaccine Research Highlights July 8, 1996
AIDS Vaccine Research Subcommittee (AVRS), Dec 2007, HIV/AIDS, Vaccines, DAIDS, NIAID, NIH June 23, 2008
AIDS Vaccine Research Subcommittee (AVRS), May 2008, HIV/AIDS, Vaccines, DAIDS, NIAID, NIH July 17, 2008
AIDS Vaccine Research Working Group (AVRWG) Sept. 11, 2008
AIDS Vaccine Research Working Group (AVRWG) Committee Members, NIAID, NIH Dec. 14, 2007
AIDS Vaccine Research Working Group Archived Meeting Summaries, NIAID, NIH Oct. 18, 2007
AIDS Virus Reformatted to Shuttle Repair Genes to Diseased Brains April 11, 1996
Airborne Allergies: Something in the Air Feb. 12, 2008
Alan Sher, Immunobiology Section, Laboratory of Parasitic Diseases, NIAID, NIH Feb. 4, 2008
Alasdair M. Gilfillan, Ph.D., Mast Cell Biology Section, Laboratory of Allergic Diseases, NIAID, NIH July 8, 2008
Albert Z. Kapikian, M.D., Epidemiology Section, Laboratory of Infectious Diseases, NIAID, NIH May 22, 2006
Alfonso Gozalo, D.V.M., M.S., Veterinary Care, Comparative Medicine Branch, NIAID, NIH June 27, 2006
Alison McBride Ph.D., DNA Tumor Virus Section, Laboratory of Viral Diseases, NIAID, NIH Sept. 19, 2008
Allergic Diseases, NIAID, NIH April 24, 2008
Allergy / Immunology Fellowship Application Process, NIAID, NIH Dec. 26, 2007
Allergy and Immunology Training Program in the Division of Intramural Research (DIR), NIAID, NIH Nov. 13, 2006
Allergy News Releases, NIAID, NIH June 30, 2008
Allergy, Immunology, and Transplantation Research Committee, About NIAID, NIAID, NIH March 9, 2005
Alsner.pdf April 9, 2008
Alteration in Cell Death Pathway Sheds Light on Autoimmune Disease July 8, 1999
Amendment #1 (Questions and Answers) to RFP NIH-NIAID-DMID-BAA-03-38, “Biodefense Proteomics Research Programs: Identifying Targets for Therapeutic Interventions Using Proteomic Technology” Sept. 12, 2007
Amendment #1 (Questions and Answers) to RFP-NIH-NIAID-DMID-03-34, "Biodefense and Emerging Infections Research Resources Program" Sept. 12, 2007
Amendment #1 to RFP NIH-NIAID-DMID-03-54, “Construction Quality Management (CQM) Support Services” Sept. 12, 2007
Amendment #1 to RFP-NIH-NIAID-DAIT-04-38 Sept. 12, 2007
Amendment #1 to RFP-NIH-NIAID-DMID 04-34, "Bioinformatics Resource Centers for Biodefense and Emerging/Re-emerging Infectious Diseases" Sept. 12, 2007
Amendment #1 to RFP-NIH-NIAID-DMID-03-29, "Production and Testing of Anthrax Recombinant Protective Antigen (rPA) Vaccine” Sept. 12, 2007
Amendment #1 to RFP-NIH-NIAID-DMID-03-45, "Administrative Resource for Biodefense Proteomic Centers" Sept. 12, 2007
Amendment #1, RFP NIH-NIAID-DMID-04-40, In Vitro and Animal Models for Emerging Diseases and BioDefense Sept. 12, 2007
Amendment #2 (Questions and Answers) to RFP-NIH-NIAID-DMID 04-34, "Bioinformatics Resource Centers for Biodefense and Emerging/Re-emerging Infectious Diseases" Sept. 12, 2007
Amendment #2 to RFP NIH-NIAID-DMID-03-45, “Administrative Resource for Biodenfense Proteomic Centers” Sept. 12, 2007
Amendment #2 to RFP NIH-NIAID-DMID-BAA-03-38, “Biodefense Proteomics Research Programs: Identifying Targets for Therapeutic Interventions Using Proteomic Technology” Sept. 12, 2007
Amendment #2 to RFP-NIH-NIAID-DMID-03-29, "Production and Testing of Anthrax Recombinant Protective Antigen (rPA) Vaccine” Sept. 12, 2007
Amendment #2 to RFP-NIH-NIAID-DMID-03-34, "Biodefense and Emerging Infections Research Resources Program" Sept. 12, 2007
Amendment #3 to RFP NIH-NIAID-DMID-BAA-03-38, “Biodefense Proteomics Research Programs: Identifying Targets for Therapeutic Interventions Using Proteomic Technology” Sept. 12, 2007
Amendment #3 to RFP-NIH-NIAID-DMID 04-34 Sept. 12, 2007
Amendment #3 to RFP-NIH-NIAID-DMID-03-29 Sept. 12, 2007
Amendment #4 to RFP NIH-NIAID-DMID-BAA-03-38 Sept. 12, 2007
Amendment #4, to RFP NIH-NIAID-DMID-03-45, “Administrative Resource for Biodenfense Proteomic Centers” Sept. 12, 2007
Amendment #5 to RFP NIH-NIAID-DMID-BAA-03-38 Sept. 12, 2007
Amendment of NIAID Solicitation RFP NIH-NIAID-DMID-03-39, "In vitro and Animal Models for Emerging Diseases and Biodefense" Sept. 12, 2007
Amino Acid Analysis and Conjugation Efficiency Assays, Technology, Peptide Synthesis, Research Technologies Branch, NIAID, NIH May 15, 2008
Amphipathic Oral Chelators and Radionuclide Contamination Dec. 26, 2007
An Ecologic Study of Prostate-specific Antigen Screening and Prostate Cancer Mortality in Nine Geographic Areas of the United States July 20, 2007
An HIV Vaccine — Evolving Concepts, NEJM, May 16, 2007 April 11, 2008
An HIV Vaccine — Evolving Concepts, NEJM, May 16, 2007 Aug. 6, 2007
An HIV/AIDS Research Agenda in Developing Countries must be:, Slide 3, Dr. Esparza, July 7, 2001 July 6, 2001
An Ontological Representation of Complex Immunological Networks (Computing with Biological Knowledge) - Lindsay G. Cowell, Duke University Center for Computational Immunology July 24, 2007
An Open Label Non-Randomized Dose Escalating Trial to Assess Safety and Tolerability of Alb-interferon Alfa 2b Every Two Weeks with Ribavirin Among HIV/HCV Coinfected Individuals May 15, 2008
Analyses, Technology, Mass Spectrometry, Research Technologies Branch, NIAID, NIH March 21, 2007
Andreassen.pdf April 9, 2008
Animal Models for Experimental Therapeutics and Vaccines Application Process, Services, DMID, NIAID, NIH July 7, 2008
Animal Models for Experimental Therapeutics and Vaccines Assurances, Services, DMID, NIAID, NIH July 7, 2008
Animal Models for Experimental Therapeutics and Vaccines Eligibility, Services, DMID, NIAID, NIH July 7, 2008
Animal Models for Hepatitis B and C Application, Services, DMID, NIAID July 3, 2008
Animal Models for Hepatitis B and C Assurances, Services, DMID, NIAID July 2, 2008
Animal Models for Hepatitis B and C Eligibility, Services, DMID, NIAID July 2, 2008
Animal Models for Hepatitis B and C Review, Services, DMID, NIAID July 3, 2008
Animal Models for Hepatitis B and C, Services, DMID, NIAID July 14, 2008
Animal Models for the Evaluation of Experimental Therapeutics and Vaccines Review Process, Services, DMID, NIAID, NIH July 7, 2008
Animal Models for the Evaluation of Experimental Therapeutics and Vaccines, Services, DMID, NIAID, NIH July 14, 2008
Animal Models, HIV/AIDS Vaccine Research, NIAID, NIH June 21, 2006
Animal Rule II: CDER Perspective/Case Studies, NIAID Workshop on Aerosolization Technolgies, December 4, 2003 Sept. 12, 2007
Animal Studies, Vaccines, NIAID, NIH July 17, 2008
Ankara Awards, Biodefense, NIAID, NIH Dec. 20, 2006
Ankara Awards, Biodefense, NIAID, NIH Dec. 20, 2006
Announcement of Availability of Overlapping Peptides for Influenza Proteome, January 27, 2006, Public Health Service, DHHS Aug. 6, 2007
Announcement of Funds Available for Pilot Grants from the Fred Hutchinson Cancer Research Center/ University of Washington Center for Medical Countermeasures Against Radiation (CMCR) Aug. 6, 2007
Announcement of Funds Available for Pilot Grants from the Fred Hutchinson Cancer Research Center/ University of Washington Center for Medical Countermeasures Against Radiation (CMCR), December 21, 2005 Aug. 6, 2007
Annual Commemerative Days, NIAID, NIH May 16, 2008
Anthony Fauci '58, Regis Alumni News Winter July 27, 2007
Anthony S. Fauci Awarded 2001 Frank Annunzio Award Oct. 4, 2001
Anthony S. Fauci Awarded Lasker Award for Public Service Sept. 14, 2007
Anthony S. Fauci Awarded the Highest Honor of the Association of American Physicians, NIAID, NIH April 13, 2007
Anthony S. Fauci to Present New Data on HIV Escape Mechanisms and HIV Suppressor Molecules Jan. 28, 1996
Anthony S. Fauci, M.D., Immunopathogenesis Section, Laboratory of Immunoregulation, NIAID, NIH May 12, 2008
Anthony S. Fauci, M.D., Lab Photo, 2007, NIAID, NIH April 13, 2007
Anthrax Awards, Biodefense, NIAID, NIH Dec. 20, 2006
Anthrax Genome Decoded April 30, 2003
Anthrax, NIAID, NIH Aug. 22, 2008
Antibiotic Therapy, Lyme Disease, NIAID, NIH Dec. 6, 2007
Antibodies Gone Awry, Multiple Sclerosis, NIAID, NIH Dec. 15, 2006
Antifungal Drug Helps Kids with Immune Disorder Avoid Hospitalization June 11, 2003
Antigen Research, Malaria Vaccine Development Branch, NIAID, NIH May 15, 2008
Antigenic Drift Illustration, How the Flu Virus Changes, Flu (Influenza), NIAID, NIH Dec. 4, 2006
Antigenic Drift vs. Antigenic Shift, How the Flu Virus Changes,Flu (Influenza), NIAID, NIH Dec. 4, 2006
Antigenic Shift Illustration, How the Flu Virus Changes,Flu (Influenza), NIAID, NIH Dec. 4, 2006
Anti-Herpes Drug Does Not Reduce Risk of HIV Infection in People with Genital Herpes Virus, Study Finds Feb. 6, 2008
Anti-HIV Treatment Improves Immune System and Fights Sight-Threatening Eye Infection Nov. 2, 1999
Antimicrobial (Drug) Resistance Research in NIAID Labs, NIH March 21, 2008
Antimicrobial (Drug) Resistance, NIAID, NIH June 16, 2008
Antimicrobial (Drug) Resistance: A Growing Health Issue, NIAID, NIH March 4, 2008
Antimicrobial Resistance - Selected Scientific Areas of Research Dec. 23, 2004
Antimicrobial Resistance News Releases, NIAID, NIH March 10, 2008
Antimicrobial Resistance: The NIH Response to a Growing Problem, Table of Contents, Dr. Anthony S. Fauci Feb. 23, 1999
Antimicrobial Resistance: The NIH Response to a Growing Problem. Statement of Anthony S. Fauci, MD, Director, National Institute of Allergy and Infectious Diseases, National Institutes of Health, February 25, 1999 Sept. 13, 1999
Antiretroviral Therapy (ART) to Reduce the Transmission of HIV, NIAID, NIH April 21, 2008
Antiviral Drug Development for Biothreat Agents - Tove Bolken, SIGA Technologies, Inc. Sept. 7, 2007
Appendices July 26, 2007
Appendices Aug. 6, 2007
Appendices - NIAID Profile FY 2003 Dec. 23, 2004
Appendix 1: DAIDS Guidance for Protocol Documents, NIAID, NIH Aug. 6, 2007
Appendix 1: Data Management Requirements for Data Collection Sites Aug. 6, 2007
Appendix 1: Essential Documents Recordkeeping Requirements Aug. 6, 2007
Appendix 1: Guidance on Study Monitoring Reports Aug. 6, 2007
Appendix 1: Required Site SOPS Aug. 6, 2007
Appendix 1: Source Documentation Requirements Aug. 6, 2007
Appendix 2: DAIDS Requirements for Non-U.S. Laboratories Guidance to Investigators Applying for Funding to Conduct HIV/AIDS Clinical Trials Aug. 6, 2007
Appendix 2: Data Management Requirements for Central Data Management Facilities Aug. 6, 2007
Appendix 2: Manual of Operations (MOP) Sample Table of Contents Aug. 6, 2007
Appendix 2: Study Progress and Safety Monitoring Plan Template Aug. 6, 2007
Appendix 3: Statistical Requirements Aug. 6, 2007
Appendix 6: DAIDS Independent Safetly Monitor (ISM) Guidelines Aug. 6, 2007
Appendix A 1 Oct. 9, 2007
Appendix A: Aerosol System Flow Oct. 9, 2007
Appendix A: Strategic Plan for Biodefense Research Sept. 7, 2007
Appendix B: Covered Sort Chamber Oct. 9, 2007
Appendix C: AeroTech Device Oct. 9, 2007
Appendix D: Position of the AeroTech Device Oct. 9, 2007
Appendix E: Glo-Germ Oct. 9, 2007
Appendix F: Collected Particles Oct. 9, 2007
Appendix G: Aerosol Cont. Report Oct. 9, 2007
Appendix H: Flow Lab Warning Oct. 9, 2007
Appendix I: Bio-Safety Suite Oct. 9, 2007
Appendix J: References Oct. 9, 2007
Application Information, Working at NIAID, NIH March 30, 2001
Application Process, Proteomics Research Centers, DMID, NIAID, NIH July 10, 2008
Application Process, Services for Preclinical Development of Therapeutic Agents, DMID, NIAID, NIH June 20, 2008
Application Process, Summer Internship Program in Biomedical Research, OTSEP, NIAID, NIH July 13, 2006
Approach to the Development of an HIV Vaccine, Poster 24 Jan. 18, 1999
Approaches to HIV Prevention, Poster 6 Jan. 18, 1999
Approaches to HIV Prevention, Slide 27, Dr. Anthony S. Fauci, July 7, 2001 July 7, 2001
Approaches to HIV Prevention, Slide 6, Dr. Anthony S. Fauci, September 16, 1998 Jan. 14, 1999
Approaches to HIV Prevention, Slide 7, Dr. Anthony S. Fauci, July 9, 1999 July 16, 1999
Approaches to Potency Assays of Pre-and Prepro-Biologic Vaccines: The Role of RT-PCR and Genetic Stability in Characterizing Potency of Plasmnid DNA-based Vaccines April 11, 2008
Approval Process, Proteomics Research Centers, DMID, NIAID, NIH July 14, 2008
Approved Anit-HIV Drugs, Slide 5, Dr. Anthony S. Fauci, September 16, 1998 Jan. 14, 1999
Approved Anti-HIV Drugs, Slide 19, Dr. Anthony S. Fauci, July 7, 2001 July 7, 2001
Approved Anti-HIV Drugs, Slide 5, Dr. Anthony S. Fauci, July 9, 1999 July 16, 1999
Architectural Rendering, Building 33, NIAID, NIH May 1, 2006
Archive of Conferences and Meetings SummariesDivision of Allergy, Immunology, and Transplantation (DAIT), NIAID, NIH Aug. 9, 2005
Archive of NIAID in the News June 17, 2005
Arnold S. Kirshenbaum, M.D., Mast Cell Biology Section, Laboratory of Allergic Diseases, NIAID, NIH March 22, 2005
Article in Press, K.-L. Nguyen et al., Virology 2004 Aug. 1, 2007
Articles & Multimedia, Biodefense, NIAID, NIH Dec. 18, 2006
Ascariasis, NIAID, NIH Aug. 1, 2008
Asexual Blood-Stage Vaccines, Malaria Vaccine Development Branch, NIAID, NIH May 15, 2008
Ashish Jain, M.D., Clinical Immunology Unit, Laboratory of Host Defenses, NIAID, NIH March 12, 2008
Assay Requirements April 11, 2008
Assaying Potency of Novel Vaccines April 10, 2008
Assays For An AAV Vectored HIV Vaccine April 11, 2008
Assays for Bovine Viruses April 11, 2008
Association of American Physicians Presidential Address: The AIDS Model: Scientific and Policy Lessons for the 21st Century, Anthony S. Fauci July 19, 2007
Assurances, Preclinical Development of Therapeutic Agents, DMID, NIAID, NIH July 15, 2008
Asthma and Allergic Diseases, Selected Scientific Areas of Research Dec. 23, 2004
Asthma Facts, NIAID, NIH Sept. 3, 2008
Asthma News Releases Sept. 18, 2008
Asthma Research in NIAID Labs, NIAID, NIH April 29, 2008
Asthma Researchers Present New Results, New Perspectives on the Disease Feb. 25, 2002
Asthma, NIAID, NIH Sept. 19, 2008
Aton Pharma Dec. 26, 2007
Atopic Awards, Biodefense, NIAID, NIH Dec. 28, 2006
Attachment II: Safety Monitoring Committee (SMC) Guidelines, DMID, NIAID, NIH Aug. 6, 2007
Attachment III: Independent Safety Monitor (ISM) Guidelines, NIAID, NIH Aug. 6, 2007
Auchincloss Statement 10.4.07 May 12, 2008
Aug. 11, 2004 - Work on the Building Interior May 2, 2006
Augmented Designs to Assess Immune Response in Vaccine Trials Aug. 6, 2007
Australia, Western Pacific, Global Research, NIAID, NIH Nov. 9, 2007
Autoimmune Disease New Releases Aug. 13, 2008
Autoimmune Diseases - Selected Scientific Areas of Research Dec. 23, 2004
Autoimmune Diseases Research Plan, NIAID, NIH Sept. 14, 2007
Autoimmune Diseases, NIAID, NIH March 28, 2006
Autoimmune Lymphoproliferative Syndrome (ALPS), NIAID, NIH May 30, 2008
Autoimmune Reactivity, Lyme Disease, NIAID, NIH Dec. 6, 2007
Avian Influena - Pandemic Preparedness Dec. 26, 2007
AVRS May 2007 Summary Oct. 19, 2007
AVRSWorkshopAgendaSept2008.pdf Sept. 15, 2008
AVRWG Advice on Adenovirus Vectors, Jan 07, DAIDS, NIAID, NIH Aug. 6, 2007
AVRWG Workshop Summary, January 07, DAIDS, NIAID, NIH Aug. 6, 2007
Award Will Boost HIV/AIDS Research in China June 28, 2002
Awardees, Medical Countermeasures Against Radiological and Nuclear Threats, NIAID, NIH Oct. 5, 2007
Awards, Bioinformatics Resource Centers, NIAID, NIH Sept. 19, 2008
Awards, Centers of Excellence for Influenza Research and Surveillance, NIAID, NIH July 24, 2008
Awards, In Vitro and Animal Modules, Biodefense, NIAID, NIH March 10, 2008
Awards, Proteomics Research Centers, DMID, NIAID, NIH April 15, 2008